This episode of #ExpertAnswers features Dr. Jerrold Turner, who is a Professor of pathology at Harvard Medical School and a Professor of Medicine at Briggam and Women’s hospital. Dr. Turner recently joined us for a webinar to discuss the barrier function of the intestine, how the permeability of tight junctions in the gut epithelium is modulated, and the impact of this modulation on homeostasis and health.
For more information or to watch the webinar, click here.
Associated Webinar: Conversations Between Mucosal Immunity and the Gut Barrier
#ExpertAnswers: Kosuke Minamihata and Jes Kuruvilla on Synthetic Peptides for Regenerative Medicine
Kosuke Minamihata and Jes Kuruvilla discuss how synthetic growth factors work and give application examples using these synthetic peptides for cell therapy and regenerative medicine.
#ExpertAnswers: Sam Sternberg on Genome Engineering
Sam Sternberg discusses a novel CRISPR-Cas9 system using programmable, RNA-guided transposase and highlighting its implications for genome engineering in cell and gene therapies.
Industry Insights with Crown Bioscience: Analyzing the Suppressive TME in In Vitro Based Assays
Nataliia Beztsinna and Marten Hornsveld from Crown Bioscience talk about native and reconstituted TME assays, how they can help in the preparation for clinical trials, and what kinds of therapies in development would benefit the most from this kind of testing.
Save Time and Money When Prioritizing Drug Candidates: Using Cell-Based Reporter Assays for Nuclear Receptor Profiling
Dr. Jack Vanden Heuvel discusses the use of cell-based reporter assays for nuclear receptor profiling to efficiently prioritize drug candidates and minimize off-target effects.
Fast-Forward Your Custom Antibody Generation With Four Bio-Rad Services
Discover how Bio-Rad's bioanalytical services and SpyTag-SpyCatcher technology can speed up custom antibody generation and improve assay flexibility for challenging targets.
Evaluation of TruVivo, an All-Human Hepatocyte Model for Mechanistic DMPK Investigations
Join Diane Ramsden, PhD, and Lindsey Whaley, MS, for an inside look at TruVivo™, a novel all-human in vitro hepatocyte system developed by LifeNet Health LifeSciences.